TYRA Description — Tyra Biosciences Inc

Tyra Biosciences is an oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Co. is focused on developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor, or FGFR family. Co.'s lead product candidate, TYRA-300, is designed to selectively inhibit Fibroblast Growth Factor Receptor3, with an initial focus on patients with bladder cancer. In addition, Co. has pipeline development programs targeting FGFR2-related cancers, FGFR3-related achondroplasia, REarranged during Transfection kinase, and FGFR4-related cancers.

Company Name: 
Tyra Biosciences Inc
Drugs & Pharmaceuticals
Number of ETFs Holding TYRA: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   TYRA Weight   TYRA Amount 
 VTI   0.00%   $5,981,276         
 IWM   0.01%   $4,290,540         
 VXF   0.00%   $2,569,917         
 IWN   0.02%   $2,108,409         
 VTWO   0.01%   $564,170         
 IWC   0.05%   $449,006         
 VTWV   0.02%   $183,972         
 URTY   0.01%   $13,435         
 VTHR   0.00%   $9,641         
 UWM   0.01%   $9,548         
List of all 11 ETFs holding TYRA »
Quotes delayed 20 minutes

Email EnvelopeFree TYRA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (4.00 out of 4)
76th percentile
(ranked higher than approx. 76% of all stocks covered)
Based on data provided by Zacks Investment Research via

ETFs Holding TYRA | Tyra Biosciences Inc | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.